Insights to help you understand and address the complexities of adaptive trial design and execution.
Read this white paper to learn how you can leverage these systems for maximum benefit in observational studies and pragmatic clinical trials.
ICON whitepaper which deconstructs the critical challenges to achieving mandates for cost efficiency and productivity.
The upcoming addendum focuses on three key areas; technology validation and certification, risk based quality management systems and increased oversight.
Specific ideas and innovative approaches that can make a real difference to the successful conduct of industry-sponsored oncology clinical trials.
ICON sponsored research outlines partnership strategies to optimise clinical drug development.
BYOD promises greater patient-centricity and will make study management less complex.
ICON and ICHOM working to develop risk-adjusted, international benchmarks on health outcomes by medical condition.
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.